Sildenafil Tablet
Product Images NDC 70518-4596

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 70518-4596). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Sildenafil Tablet 20 mg oral tablet packaged as a single tablet with quantity 1. The label shows NDC 70518-4596-01 and identifies RemedyRepack Inc. as the repackager located in Indiana, PA. It includes storage instructions and a QR code on the label. The manufacturer is Amneal Pharma in Bridgewater, NJ.*

FDA Label Image

Mm1 (Sildenafil 20mg 70518 4596 00)

Sildenafil 20 mg tablet package label showing quantity of 250 tablets per box. The label includes the NDC number, storage instructions, and repackaging information by RemedyRepack Inc., Indiana, PA. Text indicates the tablet is round, white, and for prescription use only.*

FDA Label Image

4 (Sildenafil Tablets 20mg 1)

Chemical structure of Sildenafil shown in a detailed 2D molecular diagram, illustrating its constituent atoms and bonds including heterocyclic rings, sulfonamide group, and carboxylic acid functional groups.*

FDA Label Image

1 (Sildenafil Tablets 20mg 2)

A horizontal bar chart showing drug interaction fold changes with Sildenafil, including Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir. It presents fold change and 90% confidence intervals for AUC and Cmax, with recommendations ranging from no dose adjustment to coadministration not recommended. The chart compares changes relative to Sildenafil alone, marked by a vertical line at 1.*

FDA Label Image

1 (Sildenafil Tablets 20mg 3)

A chart displaying fold change and 90% confidence intervals for various interacting drugs relative to their effect alone, alongside dosage recommendations. The x-axis shows change relative to interacting drug alone from 0.5 to 2, with a vertical reference line at 1. Drugs like Acenocoumarol and Aspirin indicate no dose adjustment, while Bosentan and Ritonavir coadministration are not recommended. The chart includes annotations explaining dosing and parameter definitions, supporting drug interaction assessment for Sildenafil tablets.*

FDA Label Image

F7c6df1a-figure-05 (Sildenafil Tablets 20mg 4)

A line graph comparing changes from baseline in meters over weeks 4, 6, and 12, for different treatment groups including Sildenafil 40 mg TID, Sildenafil 80 mg TID, Sildenafil 20 mg TID, and placebo. The x-axis represents weeks of study, and the y-axis shows change from baseline in meters with error bars for variability.*

FDA Label Image

10.1 (Sildenafil Tablets 20mg 5)

A forest plot showing placebo-corrected changes in 6-minute walk distance in meters for Sildenafil 20 mg taken three times daily (TID). The plot compares different subgroups based on baseline walk distance, etiology, pulmonary hypertension criteria, gender, age, mean pulmonary artery pressure, and pulmonary vascular resistance index, with data points and confidence intervals indicating treatment effects.*

FDA Label Image

F7c6df1a-figure-07 (Sildenafil Tablets 20mg 6)

A Kaplan-Meier survival curve chart comparing the percentage without a clinically worsening event over days from randomization, showing two lines: one for Placebo (solid) and one for Sildenafil (dotted). The chart tracks data over 112 days, with the Sildenafil line generally maintaining higher percentages than Placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.